Genesis Therapeutics

ML Research Intern - PhD (Fall 2025)

Sorry, this job was removed at 04:14 p.m. (CST) on Wednesday, Jun 25, 2025

Be an Early Applicant

Burlingame, CA, USA

Hybrid

Artificial Intelligence • Biotech

The Role

About the Team

We’re a tight-knit team of proven drug hunters, deep learning researchers, and software engineers united by a common mission — drive AI innovation in biochemistry, discovering and developing groundbreaking therapies for patients suffering from severe disorders.

Genesis AI team is focused on developing foundation models for small molecule drug discovery by conducting fundamental research at the intersection of machine learning, physics, and computational chemistry, as well as engineering robust software systems that enable running large scale simulations and training generative and predictive AI models designed to learn from all kinds of molecular data, leveraging our cluster with 1000s of GPUs and 10,000s of CPUs.

About the Role

We’re looking for exceptional ML Research Interns interested in conducting cutting edge research in a fast-paced industry setting and drive forward our ML research agenda for generative modeling of molecular systems, which is instrumental to our mission.

As a ML Research Intern at Genesis, you will work alongside our ML researchers and engineers on a high-impact research project. Majority of our internship projects focus on validating new ideas and developing novel methods that improve AI capabilities of our GEMS platform, blending together techniques from cutting edge machine learning (denoising diffusion, equivariant architectures, self-supervised training of multi-modal models, RL-based alignment) and computational physics/chemistry (molecular dynamics, quantum mechanics).

Genesis is a highly-collaborative and cross functional environment, and you will work in close partnership with our exceptional engineers, researchers, and biochemistry experts.

You will

Lead a research project, which will be broadly focused on a problem related to generative or predictive modeling of molecular systems.
Navigate the latest deep learning literature, extracting insights from generative modeling in adjacent domains (language, images, 3D graphics, etc.), develop novel models and training techniques for molecular data, and communicate your findings to the team.
Carefully design and run experiments at scale to validate most promising approaches and hypotheses.

You are

Currently enrolled in a PhD program in Computer Science, Machine Learning, or related fields.
Strong background in machine learning, deep learning, and/or related areas.
A deep thinker who reasons from first principles over pattern matching.
Interested in learning about biochemistry and the drug development process.

What we offer

The opportunity to work on challenging, high impact ML research that is immediately deployed to accelerate the discovery of new medicines.
One-on-one mentorship to help guide your research and act as a point person for questions.
Strong technical coworkers in AI, software, and chemistry, who all have a powerful mix of intellectual curiosity and humility. The team reads and discusses 1-2 ML or chemistry papers every week to stay on top of the field and inspire new ideas.

Genesis Therapeutics is unifying AI and biotech to discover novel and breakthrough treatments for patients with severe and devastating conditions. Genesis was founded on groundbreaking molecular ML research and since has established itself as the industry leader in AI for small molecule drug discovery. Our team of accomplished biotech leaders and expert drug hunters joins forces with deep learning researchers and software engineers who are pioneering predictive and generative AI technologies for molecules.

Our team has created the industry's most advanced molecular AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery and to enable the discovery of novel first-in-class and best-in-class small molecule drugs for challenging and/or undruggable targets.

The company has leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has signed AI-focused platform collaborations with major pharmaceutical companies, including most recently Incyte Corporation (Feb 2025) and Gilead Sciences (Sept 2024).

We raised a $200M series B in August 2023, and have raised over $300M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures.

Genesis is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.

View all jobs at Genesis Therapeutics

View Genesis Therapeutics Profile

Report Job

Similar Jobs

ServiceNow

Automation Engineer

Artificial Intelligence • Cloud • HR Tech • Information Technology • Productivity • Software • Automation

Remote or Hybrid

Mountain View, CA, USA

28000 Employees

ServiceNow

Software Engineer

Artificial Intelligence • Cloud • HR Tech • Information Technology • Productivity • Software • Automation

Remote or Hybrid

Santa Clara, CA, USA

28000 Employees

126K-195K Annually

ServiceNow

Director, Head of Editorial & Thought Leadership

Artificial Intelligence • Cloud • HR Tech • Information Technology • Productivity • Software • Automation

Remote or Hybrid

San Francisco, CA, USA

28000 Employees

180K-281K Annually

Boeing

Software Engineer

Aerospace • Information Technology • Software • Cybersecurity • Design • Defense • Manufacturing

In-Office

Seal Beach, CA, USA

170000 Employees

106K-144K Annually

Get Personalized Job Insights.

Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company

HQ: Burlingame, CA

58 Employees

What We Do

Genesis Therapeutics is unifying AI and biotech to accelerate and optimize drug discovery. We pioneer novel deep learning and molecular simulation techniques to accelerate the development of new medicines. Genesis raised its $52M Series A from top tech + biotech investors, Andreessen Horowitz, Rock Springs, and T. Rowe Price. Story: https://techcrunch.com/2020/12/02/genesis-therapeutics-raises-52m-a-round-for-its-ai-focused-drug-discovery-mission/ We deploy our technology to accelerate a pipeline of several internal drug programs. Furthermore, Genesis has announced two significant, multi-target collaborations with Genentech and with Eli Lilly, the latter of which entailed a $20M upfront payment with a $670M total deal size. Now we are scaling the team and technology to support many more programs in parallel as well as increasingly difficult protein targets. We currently have a team (genesistherapeutics.ai/company.html#team) of about 35 people, split 50/50 between our ML / software team and our biochem team of veteran drug hunters in our own wetlab space. Our ML + software engineers are top-notch -- many graduates from MIT, UC Berkeley, Stanford. Previously worked at OpenAI, Google, Facebook, MemSQL, Jane Street, Dropbox, etc. We're recruiting pure ML research scientists + software engineers (no bio or chem experience expected) to further our core AI platform as well as scale our drug pipeline. Likewise, we have several openings in chemistry and biology to join our team of biotech + pharma veterans who are deploying the Genesis ML platform to discover novel drug candidates. Please apply on our website, or feel free to reach out via email directly: [email protected]